0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
How Radiopharmaceuticals Are Fighting Cancer in ChinaCancer is a leading cause of death in China, and early diagnosis is critical. Radiopharmaceuticals are helping detect tumors earlier and treat them more precisely. From PET imaging that reveals metastatic spread to radionuclide therapies that target cancer cells, these drugs are changing cancer care. In diagnosis, radiopharmaceuticals enable whole-body imaging that reveals tumors and their...0 Comments 0 Shares 532 Views 0 Reviews
-
Key Drivers Shaping the Spain Radiopharmaceuticals MarketThe Spain Radiopharmaceuticals Market growth continues to accelerate as radioembolisation with Yttrium-90 microspheres establishes itself as a standard treatment for primary and metastatic liver tumours. With hepatocellular carcinoma incidence rising in Spain linked to hepatitis C history and metabolic liver disease, and with colorectal cancer liver metastases representing a major oncological...0 Comments 0 Shares 521 Views 0 Reviews
-
Nuclear Medicine Radiopharmaceuticals Market Size, Share & Growth Analysis | 20.23% CAGR Through 2033The Nuclear Medicine Radiopharmaceuticals Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Management should view the market as a...0 Comments 0 Shares 130 Views 0 Reviews
-
Radiopharmaceuticals Market Outlook: Key Opportunities in Precision OncologyValued at USD 8.63 billion in 2025, the market is projected to reach USD 8.63 billion in 2026 and USD 20.94 billion by 2034, growing at a CAGR of 10.40% during the forecast period 2026–2034. The steady expansion of the global Radiopharmaceuticals Market is significantly propelled by the increasing prevalence of oncological and cardiovascular disorders globally, coupled with an aging...0 Comments 0 Shares 295 Views 0 Reviews
-
Rising Demand for Precision Oncology Fuels Radiopharmaceuticals Market GrowthIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Comments 0 Shares 2K Views 0 Reviews
-
Saudi Arabia and UAE Lead the GCC Radiopharmaceuticals MarketSaudi Arabia and the UAE are leading the GCC Radiopharmaceuticals Market, driven by ambitious healthcare transformation agendas, significant infrastructure investment, and growing cancer care capacity. Saudi Vision 2030 includes substantial investment in healthcare, including oncology centres and nuclear medicine facilities. The UAE's healthcare investment programmes and medical tourism...0 Comments 0 Shares 355 Views 0 Reviews
-
Targeted Radiopharmaceuticals and PET Imaging Tracers Advancing Precision Molecular OncologyThe rapid evolution of molecular imaging technology and targeted nuclear medicine is driving steady growth across the global diagnostic radiopharmaceutical sector. Detailed analysis within the Imaging Tracer Market report demonstrates how novel positron emission tomography (PET) and single-photon emission computed tomography (SPECT) tracers are revolutionizing early disease detection. Advanced...0 Comments 0 Shares 203 Views 0 Reviews
-
Molybdenum-99 Market Outlook 2025–2033: Sustaining Healthy CAGR Amid Intensifying Competitive DynamicsMolybdenum 99 Market Overview A new report titled “Global Molybdenum 99 Market Professional Report 2025-2033” has been added by Straits Research to its repository of research reports. The report analyzes and estimates the market on a global, regional, and country level. The report offers data from previous years along with an in-depth analysis from 2025 to 2033 on the basis of...0 Comments 0 Shares 877 Views 0 Reviews
-
Nuclear Medicine Market Forecast Points to Strong Expansion Through 2036The Nuclear Medicine Market is projected to grow from USD 21.3 billion in 2025 to USD 61.4 billion by 2036 at a 10.1% CAGR, according to Fact.MR. ROCKVILLE, MD — October 5, 2026 — The global Nuclear Medicine Market is projected to reach USD 61.4 billion by 2036, rising from USD 21.3 billion in 2025 at a compound annual growth rate of 10.1%, according to Fact.MR. The market is...0 Comments 0 Shares 259 Views 0 Reviews
-
Why Radiopharmaceutical Innovation Is Accelerating Across Asia PacificThe Asia Pacific Radiopharmaceuticals Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Asia Pacific Radiopharmaceuticals Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...0 Comments 0 Shares 499 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek